Cyclin A and cyclin E expression in resected non-small cell lung cancer stage I-IIIA

In Vivo

Volumn 23, Issue 4, 2009, Pages 519-526

  Kosacka, Monika ^a   Piesiak, Paweł ^a   Porȩbska, Irena ^a   Korzeniewska, Anna ^a   Dyła, Tomasz ^a   Jankowska, Renata ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cyclin A; Cyclin E; Non small cell lung cancer; Prognostic factor

Indexed keywords

CYCLIN A; CYCLIN E;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 67650945286     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mountain CF: The international system for staging lung cancer. Semin Surg Oncol 18(2): 106-115, 2000. (Pubitemid 30090451)
2. Skuladottir H and Olsen JH: Epidemiology of lung cancer. In: The European Respiratory Monograph: Lung Cancer. Spiro SG (ed.). ERS Journals, Ltd, Sheffield, Vol 6, Monograph 17, pp. 1-12, 2001.
3. Survival of Cancer Patients in Europe: The Eurocare-3 study. Ann Oncol, Vol.14, Supplement 2003. http://eurocare.it/
4. Welch HG, Schwartz LM and Woloshin S: Are increasing 5-year survival rates evidence of success against cancer? JAMA 283: 2975-2978, 2000.
5. Strauss GM, Kwiatkowski DJ, Harpole DH, Lynch TJ, Skarin AT and Sugarbaker DJ: Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol 13: 1265-1279, 1995.
6. Mishina T, Dosaka-Akita H, Hommura F, Nishi M, Kojima T, Ogura S, Shimizu M, Katoh H and Kawakami Y: Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin Cancer Res 6: 11-16, 2000. (Pubitemid 30064970)
7. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR and Albelda SM: Prognostic implications of cell cycle, apoptosis and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 11: 3974-3986, 2005. (Pubitemid 40791561)
8. Mac Lachlan TK, Sang N and Giordano A: Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 5(2): 127-156, 1995.
9. Caputi M, Groeger AM, Esposito V, Dean C, De Luca A, Pacilio C, Muller MR, Giordano GG, Baldia F, Wolner E and Giordano A: Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol 20: 746-750, 1999. (Pubitemid 129495786)
10. Sherr Ch J: The pezcoller lecture: Cancer cell cycles revisited. Cancer Res 60(14): 3689-3695, 2000.
11. Spruck CH, Won KA and Reed SI: Deregulated cyclin E induces chromosome instability. Nature 401(6750): 297-300, 1999. (Pubitemid 129515546)
12. Othsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M: Human cyclin E, a nuclear protein essential for the Gl-to-S phase transition. Mol Cell Biol 15(5): 2612-2624, 1995.
13. Yang R, Mueller C, Huynh V, FungYK, Yee AS and Koeffler HP: Functions of cyclin Al in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol 19: 2400-2407, 1999. (Pubitemid 29098297)
14. Rivera A, Mavila A, Bayless KJ, Davis GE and Maxwell SA: Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells. Cell Mol Life Sci 63: 1425-1439, 2006. (Pubitemid 43939022)
15. Zhu CQ, Shih W, Ling CH and Tsao MS: Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 59(8): 790-800, 2006. (Pubitemid 44211740)
16. Porebska I, Wyrodek E, Kosacka M, Adamiak J, Jankowska R and Harlozinska-Szmyrka A: Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. In Vivo 20: 599-604, 2006. (Pubitemid 44680192)
17. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjanen K and Kosma VM: Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 80(12): 2001-2007, 1999. (Pubitemid 29391288)
18. Itami A, Shimada Y, Watanabe G and Imamura M: Prognostic value of p27(Kip1) and cyclin D1 expression in esophageal cancer. Oncology 57(4): 311-317, 1999.
19. Sato Y, Itoh F, Hareyama M, Satoh M, Hinoda Y, Seto M, Ueda R and Imai K: Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma. J Gastroenterol 34(4): 486-493, 1999. (Pubitemid 29408175)
20. Bortner DM and Rosenberg MP: Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17: 453-459, 1997.
21. Lonardo F, Rusch V, Langenfeld J, Dmitrovsky E and Klimstra DS: Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 59: 2470-2476, 1999.
22. Langenfeld J, Lonardo F,Kiyokawa H, Passalaris T, Ahn MJ, Rusch V and Dmitrovsky E: Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. Oncogene 13: 1983-1990, 1996.
23. Ioachim E, Peschos D, Gousia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D and Agnantis NJ: Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinocopathological features. J Exp Clin Cancer Res 23(2): 277-283, 2004.
24. Dosaka-Akita H, Hommura F, Mishina T, Ogura S, Shimizu M, Katoh H and Kawakami Y: A risk-stratification model of non-small cell lung cancer using cyclin E, Ki-67 and ras p21. Different roles of Gl cyclins in cell proliferation and prognosis. Cancer Res 61: 2500-2504, 2001.
25. Mishina T, Dosaka-Akita H, Hommura F, Nishi M, Kojima T, Ogura S, Shimizu M, Katoh H and Kawakami Y: Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin Cancer Res 6: 11-16, 2000.
26. Yoo J, Jung JH, Lee MA, Seo KJ, Shim BY, Kim SH, Cho DG, Ahn MI, Kim CH, Cho KD, Kang SJ and Kim HK: Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sei 22(2): 318-325, 2007.
27. Dobashi Y, Jiang SX, Shoji M, Morinaga S and Kameya T: Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas. J Pathol 199(2): 208-220,2003.
28. Volm, Koomagi R, Mattern J and Stammler G: Cyclin A is associated with unfavourable outcome in patients with non-small cell lung carcinomas. Br J Cancer 75(12): 1774-1778, 1997.